Replies to post #1677 on Hepion Pharmaceuticals Inc (HEPA)

[Bertsllc]

The rest of the data from trials...

"The current findings support this potential, and we will continue to analyze additional incoming data from this trial which should allow us to better understand CRV431. We expect this additional data from the AMBITION trial in the near-term and will report it once we complete our analyses.”

https://finance.yahoo.com/news/hepion-pharmaceuticals-announces-positive-topline-120000659.html